Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Probiotics: insights and new opportunities for Clostridioides difficile intervention
Rusha Pal, Ahmad I. M. Athamneh, Riddhi Deshpande, et al.
Critical Reviews in Microbiology (2022) Vol. 49, Iss. 3, pp. 414-434
Closed Access | Times Cited: 19

Showing 19 citing articles:

Gut Microbiota and Clostridium difficile: What We Know and the New Frontiers
Andrea Piccioni, Federico Rosa, Federica Manca, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 13323-13323
Open Access | Times Cited: 42
Health Benefits of Prebiotics, Probiotics, Synbiotics, and Postbiotics
Nasser Al‐Habsi, Maha Al‐Khalili, Syed Ariful Haque, et al.
Nutrients (2024) Vol. 16, Iss. 22, pp. 3955-3955
Open Access | Times Cited: 13
Efficacy and Safety of a Probiotic Containing Saccharomyces boulardii CNCM I-745 in the Treatment of Small Intestinal Bacterial Overgrowth in Decompensated Cirrhosis: Randomized, Placebo-Controlled Study
Irina Efremova, Roman Maslennikov, М. С. Жаркова, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 3, pp. 919-919
Open Access | Times Cited: 8
The Impact of Probiotics on Oral Cancer: Mechanistic Insights and Therapeutic Strategies
Lakshmi Nandhana S S, D. Maheswary, Sujith Sri Surya Ravi, et al.
Oral Oncology Reports (2025), pp. 100715-100715
Open Access | Times Cited: 1
Potential therapeutic solution for Clostridioides difficile infection: current scenario and future prospects
Chandrashekhar Singh, Anjali Singh, Deepjyoti Singh, et al.
Medicine in Microecology (2025), pp. 100121-100121
Open Access
Non-invasive treatment of Clostridioides difficile infection with a human-origin probiotic cocktail through gut microbiome-gut metabolome modulations
Bijay Gurung, Marı́a C. Courrèges, Julie Pollak, et al.
Frontiers in Microbiology (2025) Vol. 16
Open Access
Probiotics Exert Gut Immunomodulatory Effects by Regulating the Expression of Host miRNAs
Wenjing Li, Ye Zeng, Jia‐Yu Zhong, et al.
Probiotics and Antimicrobial Proteins (2025)
Closed Access
Post-infectious ibs following Clostridioides difficile infection; role of microbiota and implications for treatment
Dana Taghaddos, Zarwa Saqib, Xiaopeng Bai, et al.
Digestive and Liver Disease (2024) Vol. 56, Iss. 11, pp. 1805-1809
Closed Access | Times Cited: 2
Evolving Advances in the Cosmetic use of Probiotics and Postbiotics: Health, Regulatory and Marketing Aspects
Rashmi Arora, Rajwinder Kaur, Ritchu Babbar, et al.
Current Pharmaceutical Biotechnology (2023) Vol. 25, Iss. 11, pp. 1349-1361
Closed Access | Times Cited: 4
Antisense inhibition of RNA polymerase α subunit of Clostridioides difficile
Rusha Pal, Mohamed N. Seleem
Microbiology Spectrum (2023) Vol. 11, Iss. 5
Open Access | Times Cited: 4
A Critical Review of Postbiotics as Promising Novel Therapeutic Agents for Clostridial Infections
Mahdi Asghari Ozma, Manouchehr Fadaee, Hamideh Mahmoodzadeh Hosseini, et al.
Probiotics and Antimicrobial Proteins (2024)
Closed Access | Times Cited: 1
Characterization of Limosilactobacillus reuteri KGC1901 Newly Isolated from Panax ginseng Root as a Probiotic and Its Safety Assessment
Hye-Young Yu, Mijin Kwon, Yun-Seok Lee, et al.
Fermentation (2023) Vol. 9, Iss. 3, pp. 228-228
Open Access | Times Cited: 3
Unveiling the inhibition mechanism of Clostridioides difficile by Bifidobacterium longum via multiomics approach
Sung‐Hyun Jo, Hyo‐Jin Jeon, Won‐Suk Song, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 2
Intestinal Microbiota: The Driving Force behind Advances in Cancer Immunotherapy
Zhujiang Dai, Jihong Fu, Xiang Peng, et al.
Cancers (2022) Vol. 14, Iss. 19, pp. 4796-4796
Open Access | Times Cited: 4
Antiviral Library Screening Leads to Discovery of Novel and Potent Anticlostridial Compounds
Brice Jasarino Stolz, Mohamed N. Seleem, Ahmed A. Abouelkhair
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Gut microbiota-centered risk factors and altered immunometabolism in the pathogenesis and prophylaxis of Clostridium difficile infection
Mοhd Saeed, Nehal Batra, Raja Rezgui, et al.
Journal of King Saud University - Science (2024) Vol. 36, Iss. 9, pp. 103374-103374
Open Access
Efficacy of Grapefruit Seed Extract and Lactic Acid Bacteria in Reducing Clostridioides difficile Infection via Gut Microbiota Modulation
Sini Kang, Yue Zhao, Linda Liu, et al.
Food Bioscience (2024), pp. 105299-105299
Closed Access
Screening novel antiviral compounds to treat Clostridioides difficile infections
Brice Jasarino Stolz, Ahmed A. Abouelkhair, Mohamed N. Seleem
PLoS ONE (2024) Vol. 19, Iss. 12, pp. e0309624-e0309624
Open Access
Bifidobacteria antagonize the life cycle of Clostridioides difficile.
P. Cecilia Soldavini Pelichotti, Manuela Martinefski, Odara Horta Boscolo, et al.
Microbial Pathogenesis (2024), pp. 107250-107250
Closed Access
Page 1

Scroll to top